William Blair Initiates Coverage On Rhythm Pharmaceuticals with Outperform Rating

William Blair analyst Alethia Young has initiated coverage on Rhythm Pharmaceuticals (NASDAQ: RYTM) with an Outperform rating. This marks a positive outlook for the company in the market.